The utility of metabolomics in natural product and biomarker characterization

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 12, 2014, Pages 3460-3474

  Cox, Daniel G ^a   Oh, Joonseok ^a   Keasling, Adam ^a   Colson, Kim L ^b   Hamann, Mark T ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b BRUKER BIOSPIN CORPORATION   (United States)

Author keywords

Diagnostic biomarker; Integrated approach; NMR; PCA; Plant metabolomics; Targeted metabolomics

Indexed keywords

BIOLOGICAL MARKER; NATURAL PRODUCT;

DATA PROCESSING; DIAGNOSTIC TEST; DRUG DEVELOPMENT; ELECTROSPRAY; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; FOURIER TRANSFORM MASS SPECTROMETRY; GAS CHROMATOGRAPHY; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYLOGENY; PROTON NUCLEAR MAGNETIC RESONANCE; QUADRUPOLE MASS SPECTROMETRY; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVIEW; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY;

EID: 84908583942     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.08.007     Document Type: Review

References (104)

1. J.E. Manson, G.A. Colditz, M.J. Stampfer, W.C. Willett, B. Rosner, R.R. Monson, F.E. Speizer, C.H. Hennekens, A prospective study of obesity and risk of coronary heart disease in women, N. Engl. J. Med. 322 (1990) 882-889.
2. D. Hinton, C. Bacon, The distribution and ultrastructure of the endophyte of toxic tall fescue, Can. J. Bot. 63 (1985) 36-42.
3. M. Tyree, Y. Cheung, M. MacGregor, A. Talbot, The characteristics of seasonal and ontogenetic changes in the tissue-water relations of Acer, Populus, Tsuga, and Picea, Can. J. Bot. 56 (1978) 635-647.
4. E. Dudley, M. Yousef, Y. Wang, W. Griffiths, Targeted metabolomics and mass spectrometry, Adv. Protein Chem. Struct. Biol. 80 (2010) 45-83.
5. G.J. Patti, O. Yanes, G. Siuzdak, Innovation: metabolomics: the apogee of the omics trilogy, Nat. Rev. Mol. Cell Biol. 13 (2012) 263-269.
6. D.B. Kell, Metabolomics and systems biology: making sense of the soup, Curr. Opin. Microbiol. 7 (2004) 296-307.
7. G.N. Gowda, S. Zhang, H. Gu, V. Asiago, N. Shanaiah, D. Raftery, Metabolomics-based methods for early disease diagnostics, Expert. Rev. Mol. Diagn. 8 (2008) 617-633.
8. E. Trujillo, C. Davis, J. Milner, Nutrigenomics, proteomics, metabolomics, and the practice of dietetics, J. Am. Diet. Assoc. 106 (2006) 403-413.
9. K. Urano, K. Maruyama, Y. Ogata, Y. Morishita, M. Takeda, N. Sakurai, H. Suzuki, K. Saito, D. Shibata, M. Kobayashi, Characterization of the ABA-regulated global responses to dehydration in Arabidopsis by metabolomics, Plant J. 57 (2009) 1065-1078.
10. A.R. Fernie, R.N. Trethewey, A.J. Krotzky, L. Willmitzer, Metabolite profiling: from diagnostics to systems biology, Nat. Rev. Mol. Cell Biol. 5 (2004) 763-769.
11. P. Devaux, M. Horning, E. Horning, Benzyloxime derivatives of steroids. A new metabolic profile procedure for human urinary steroids human urinary steroids, Anal. Lett. 4 (1971) 151-160.
12. W. Cunnick, J. Cromie, R. Cortell, B. Wright, E. Beach, F. Seltzer, S. Miller, Value of biochemical profiling in a periodic health examination program: analysis of 1,000 cases, Bull. N. Y. Acad. Med. 48 (1972) 5-22.
13. K.J. Judy, D.A. Schooley, L.L. Dunham, M. Hall, B.J. Bergot, J.B. Siddall, Isolation, structure, and absolute configuration of a new natural insect juvenile hormone from Manduca sexta, Proc. Natl. Acad. Sci. U. S. A. 70 (1973) 1509-1513.
14. J.J. Sims, M.S. Donnell, J.V. Leary, G.H. Lacy, Antimicrobial agents from marine algae, Antimicrob. Agents Chemother. 7 (1975) 320-321.
15. D.G. Kingston, M.M. Rao, W.V. Zucker, Plant anticancer agents. IX. Constituents of Hyptis tomentosa, J. Nat. Prod. 42 (1979) 496-499.
16. J. Vrbanac, W. Braselton, J. Holland, C. Sweeley, Automated qualitative and quantitative metabolic profiling analysis of urinary steroids by a gas chromatographymass spectrometry-data system, J. Chromatogr. A 239 (1982) 265-276.
17. J. Nicholson, M.P. O'Flynn, P. Sadler, A. Macleod, S. Juul, P. Sonksen, Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects, Biochem. J. 217 (1984) 365-375.
18. J.R. Bales, D.P. Higham, I. Howe, J.K. Nicholson, P.J. Sadler, Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine, Clin. Chem. 30 (1984) 426-432.
19. J. Bales, J. Bell, J. Nicholson, P. Sadler, J. Timbrell, R. Hughes, P. Bennett, R. Williams, Metabolic profiling of body fluids by proton NMR: self-poisoning episodes with paracetamol (acetaminophen), Magn. Reson. Med. 6 (1988) 300-306.
20. H. Sauter, M. Lauer, H. Fritsch, Metabolic profiling of plants: a new diagnostic technique, ACS Symp. Ser. Am. Chem. Soc. 443 (1991) 288-299.
21. C.A. Smith, G. O'Maille, E.J. Want, C. Qin, S.A. Trauger, T.R. Brandon, D.E. Custodio, R. Abagyan, G. Siuzdak, METLIN: a metabolite mass spectral database, Ther. Drug Monit. 27 (2005) 747-751.
22. L.W. Sumner, A.L. Duran, D.V. Huhman, J.T. Smith, Chapter three metabolomics: a developing and integral component in functional genomic studies of Medicago truncatula, Recent Adv. Phytochem. 36 (2002) 31-61.
23. W.B. Dunn, D.I. Ellis, Metabolomics: current analytical platforms and methodologies, TrAC Trends Anal. Chem. 24 (2005) 285-294.
24. A. Huenerbein, M.A. Sípoli Marques, A. dos Santos Pereira, F. Radler de Aquino Neto, Improvement in steroid screening for doping control with special emphasis on stanozolol, J. Chromatogr. A 985 (2003) 375-386.
25. Y. Noguchi, R. Sakai, T. Kimura, Metabolomics and its potential for assessment of adequacy and safety of amino acid intake, J. Nutr. 133 (2003) 2097S-2100S.
26. J. Dallüge, J. Beens, U.A.T. Brinkman, Comprehensive two-dimensional gas chromatography: a powerful and versatile analytical tool, J. Chromatogr. A 1000 (2003) 69-108.
27. M. Adahchour, J. Beens, R. Vreuls, U. Brinkman, Recent developments in comprehensive two-dimensional gas chromatography (GC x GC): IV. Further applications, conclusions and perspectives, TrAC Trends Anal. Chem. 25 (2006) 821-840.
28. Y. Hu, Y. Qi, H. Liu, G. Fan, Y. Chai, Effects of celastrol on human cervical cancer cells as revealed by ion-trap gas chromatography-mass spectrometry based metabolic profiling, Biochim. Biophys. Acta Gen. Subj. 1830 (2012) 2779-2789.
29. Y. Shen, R. Zhang, R.J. Moore, J. Kim, T.O. Metz, K.K. Hixson, R. Zhao, E.A. Livesay, H. R. Udseth, R.D. Smith, Automated 20 kpsi RPLC-MS and MS/MS with chromatographic peak capacities of 1000-1500 and capabilities in proteomics and metabolomics, Anal. Chem. 77 (2005) 3090-3100.
30. W. Lu, B.D. Bennett, J.D. Rabinowitz, Analytical strategies for LC-MS-based targeted metabolomics, J. Chromatogr. B 871 (2008) 236-242.
31. B. Zhou, J.F. Xiao, L. Tuli, H.W. Ressom, LC-MS-based metabolomics, Mol. Biosyst. 8 (2012) 470-481.
32. M. Scigelova, M. Hornshaw, A. Giannakopulos, A. Makarov, Fourier transform mass spectrometry, Mol. Cell. Proteomics 10 (2011).
33. Q. Hu, R.J. Noll, H. Li, A. Makarov, M. Hardman, R. Graham Cooks, The Orbitrap: a new mass spectrometer, J. Mass Spectrom. 40 (2005) 430-443.
34. R.E. March, Quadrupole ion trap mass spectrometry: a view at the turn of the century, Int. J. Mass Spectrom. 200 (2000) 285-312.
35. D.J. Douglas, A.J. Frank, D. Mao, Linear ion traps in mass spectrometry, Mass Spectrom. Rev. 24 (2005) 1-29.
36. S. Lacorte, A.R. Fernandez-Alba, Time of flight mass spectrometry applied to the liquid chromatographic analysis of pesticides in water and food, Mass Spectrom. Rev. 25 (2006) 866-880.
37. J.H. Wang, J. Byun, S. Pennathur, Analytical approaches to metabolomics and applications to systems biology, Semin. Nephrol. 30 (2010) 500-511.
38. M. Brown, D.C. Wedge, R. Goodacre, D.B. Kell, P.N. Baker, L.C. Kenny, M.A. Mamas, L. Neyses, W.B. Dunn, Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets, Bioinformatics 27 (2011) 1108-1112.
39. R. Kaddurah-Daouk, B.S. Kristal, R.M. Weinshilboum, Metabolomics: a global biochemical approach to drug response and disease, Annu. Rev. Pharmacol. Toxicol. 48 (2008) 653-683.
40. D. Arrell, A. Terzic, Network systems biology for drug discovery, Clin. Pharmacol. Ther. 88 (2010) 120-125.
41. A. O'Sullivan, R.E. Willoughby, D. Mishchuk, B. Alcarraz, C. Cabezas-Sanchez, R.E. Condori, D. David, R. Encarnacion, N. Fatteh, J. Fernandez, R. Franka, S. Hedderwick, C. McCaughey, J. Ondrush, A. Paez-Martinez, C. Rupprecht, A. Velasco-Villa, C.M. Slupsky, Metabolomics of cerebrospinal fluid from humans treated for rabies, J. Proteome Res. 12 (2012) 481-490.
42. H.R. Cho, H. Wen, Y.J. Ryu, Y.J. An, H.C. Kim, W.K. Moon, M.H. Han, S. Park, S.H. Choi, An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis, Cancer Res. 72 (2012) 5179-5187.
43. Q. Van, T. Veenstra, H. Issaq, Metabolic profiling for the detection of bladder cancer, Curr. Urol. Rep. 12 (2011) 34-40.
44. J. Zhang, S. Wei, L. Liu, G.A. Nagana Gowda, P. Bonney, J. Stewart, D.W. Knapp, D. Raftery, NMR-based metabolomics study of canine bladder cancer, Biochim. Biophys. Acta Mol. Basis Dis. 1822 (2012) 1807-1814.
45. D.W. Knapp, N.W. Glickman, D.B. DeNicola, P.L. Bonney, T.L. Lin, L.T. Glickman, Naturally-occurring canine transitional cell carcinoma of the urinary bladder, a relevant model of human invasive bladder cancer, Urol. Oncol. 5 (2000) 47-59.
46. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, M.J. Thun, Cancer statistics, 2008, CA Cancer J. Clin. 58 (2008) 71-96.
47. A. Imaizumi, N. Ono, R. Sakai, T. Ando, N. Okamoto, F. Imamura, M. Higashiyama, Lung cancer evaluating apparatus, method, system, and program recording medium therefor, US 2010/0017144A12010.
48. R.N. Fedorak, E. Wang, Methods for the assessment of colorectal cancer and colorectal polyps by measurement of metabolites in urine, US 2013/0065320A12013.
49. M.B. Potter, Strategies and resources to address colorectal cancer screening rates and disparities in the United States and globally, Annu. Rev. Public Health 34 (2013) 413-429.
50. M.D. Raftery, V.M. Asiago, G.A.N. Gowda, L. Alvarado, Early detection of recurrent breast cancer using metabolite profiling, US 2013/00230562013.
51. K. Weinberger, H. Deinger, E.I. Igwe, D. Enot, G. Dallmann, H. Klocker, Diagnosing prostate cancer relapse, US 2012/0326025A12012.
52. U. Lundin, K. Weinberger, New biomarkers for assessing kidney disease, US 2012/0129265A12012.
53. G.G. Cezar, Molecule biomarkers of autism, US 2012/0190055A12012.
54. Q. Pan, Q. Wang, F. Yuan, S. Xing, J. Zhao, Y.H. Choi, R. Verpoorte, Y. Tian, G. Wang, K. Tang, Overexpression of ORCA3 and G10H in Catharanthus roseus plants regulated alkaloid biosynthesis and metabolism revealed by NMR-metabolomics, PLoS One 7 (2012) e43038.
55. A. Mari, D. Lyon, L. Fragner, P. Montoro, S. Piacente, S. Wienkoop, V. Egelhofer, W. Weckwerth, Phytochemical composition of Potentilla anserina L. analyzed by an integrative GC-MS and LC-MS metabolomics platform, Metabolomics (2012) 1-9.
56. K. Böröczky, H. Laatsch, I. Wagner-Döbler, K. Stritzke, S. Schulz, Cluster analysis as selection and dereplication tool for the identification of new natural compounds from large sample sets, Chem. Biodivers. 3 (2006) 622-634.
57. G.K. Pierens, M.E. Palframan, C.J. Tranter, A.R. Carroll, R.J. Quinn, A robust clustering approach for NMR spectra of natural product extracts, Magn. Reson. Chem. 43 (2005) 359-365.
58. D. Krug, G. Zurek, O. Revermann, M. Vos, G.J. Velicer, R. Müller, Discovering the hidden secondary metabolome of Myxococcus xanthus: a study of intraspecific diversity, Appl. Environ. Microbiol. 74 (2008) 3058-3068.
59. J. Yuk, K.L. McIntyre, C. Fischer, J. Hicks, K.L. Colson, E. Lui, D. Brown, J.T. Arnason, Distinguishing Ontario ginseng landraces and ginseng species using NMR-based metabolomics, Anal. Bioanal. Chem. (2012) 1-11.
60. L. Boto, Horizontal gene transfer in evolution: facts and challenges, Proc. R. Soc. B Biol. Sci. 277 (2010) 819-827.
61. J.C. Clemente, K. Satou, G. Valiente, Phylogenetic reconstruction from non-genomic data, Bioinformatics 23 (2007) e110-e115.
62. C. Pál, B. Papp, M.J. Lercher, Adaptive evolution of bacterial metabolic networks by horizontal gene transfer, Nat. Genet. 37 (2005) 1372-1375.
63. J.C. Slot, A. Rokas, Horizontal transfer of a large and highly toxic secondary metabolic gene cluster between fungi, Curr. Biol. 21 (2011) 134-139.
64. R. Dieckmann, I. Graeber, I. Kaesler, U. Szewzyk, H. Von Döhren, Rapid screening and dereplication of bacterial isolates from marine sponges of the Sula Ridge by Intact-Cell-MALDI-TOF mass spectrometry (ICM-MS), Appl. Microbiol. Biotechnol. 67 (2005) 539-548.
65. G. Gauthier, M. Gauthier, R. Christen, Phylogenetic analysis of the genera Alteromonas, Shewanella, and Moritella using genes coding for small-subunit rRNA sequences and division of the genus Alteromonas into two genera, Alteromonas (emended) and Pseudoalteromonas gen. nov., and proposal of twelve new species combinations, Int. J. Syst. Bacteriol. 45 (1995) 755-761.
66. L.-X. Duan, T.-L. Chen, M. Li, M. Chen, Y.-Q. Zhou, G.-H. Cui, A.-H. Zhao, W. Jia, L.-Q. Huang, X. Qi, Use of the metabolomics approach to characterize Chinese medicinal material Huangqi, Mol. Plant 5 (2012) 376-386.
67. O. Fiehn, Metabolomics-the link between genotypes and phenotypes, Plant Mol. Biol. 48 (2002) 155-171.
68. C.W. Chang, P.C. Lyu, M. Arita, Reconstructing phylogeny from metabolic substrate- product relationships, BMC Bioinforma. 12 (2011) S27.
69. O. Fiehn, J. Kopka, P. Dörmann, T. Altmann, R.N. Trethewey, L. Willmitzer, Metabolite profiling for plant functional genomics, Nat. Biotechnol. 18 (2000) 1157-1161.
70. R.A. Dixon, L.W. Sumner, Legume natural products: understanding and manipulating complex pathways for human and animal health, Plant Physiol. 131 (2003) 878-885.
71. W.M. Claudino, P.H. Goncalves, A. di Leo, P.A. Philip, F.H. Sarkar, Metabolomics in cancer: a bench-to-bedside intersection, Crit. Rev. Oncol. Hematol. 84 (2012) 1-7.
72. R. Madsen, T. Lundstedt, J. Trygg, Chemometrics in metabolomics - a review in human disease diagnosis, Anal. Chim. Acta. 659 (2010) 23-33.
73. M. Mamas, W.B. Dunn, L. Neyses, R. Goodacre, The role of metabolites and metabolomics in clinically applicable biomarkers of disease, Arch. Toxicol. 85 (2011) 5-17.
74. C.C. Tang, K.L. Poston, V. Dhawan, D. Eidelberg, Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease, J. Neurosci. 30 (2010) 1049-1056.
75. J.B. German, S.M. Watkins, L.-B. Fay, Metabolomics in practice: emerging knowledge to guide future dietetic advice toward individualized health, J. Am. Diet. Assoc. 105 (2005) 1425-1432.
76. C. Wang, H. Kong, Y. Guan, J. Yang, J. Gu, S. Yang, G. Xu, Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis, Anal. Chem. 77 (2005) 4108-4116.
77. K. Yuan, H. Kong, Y. Guan, J. Yang, G. Xu, A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile, J. Chromatogr. B 850 (2007) 236-240.
78. 1H-NMR-based metabonomics, Nat. Med. 8 (2002) 1439-1445.
79. X. Han, D.M Holtzman, D. W McKeel, J. Kelley, J.C. Morris, Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis, J. Neurochem. 82 (2002) 809-818.
80. F. van der Kloet, F. Tempels, N. Ismail, R. van der Heijden, P. Kasper, M. Rojas-Cherto, R. van Doorn, G. Spijksma, M. Koek, J. van der Greef, Discovery of earlystage biomarkers for diabetic kidney disease using MS-based metabolomics (FinnDiane study), Metabolomics 8 (2012) 109-119.
81. L. Lin, Z. Huang, Y. Gao, X. Yan, J. Xing, W. Hang, LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery, J. Proteome Res. 10 (2011) 1396-1405.
82. M. Sugimoto, D. Wong, A. Hirayama, T. Soga, M. Tomita, Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles, Metabolomics 6 (2010) 78-95.
83. N. Spielmann, D.T. Wong, Saliva: diagnostics and therapeutic perspectives, Oral Dis. 17 (2011) 345-354.
84. M.P. Quinones, R. Kaddurah-Daouk, Metabolomics tools for identifying biomarkers for neuropsychiatric diseases, Neurobiol. Dis. 35 (2009) 165-176.
85. S. Moco, R.J. Bino, O. Vorst, H.A. Verhoeven, J. de Groot, T.A. van Beek, J. Vervoort, C. R. De Vos, A liquid chromatography-mass spectrometry-based metabolome database for tomato, Plant Physiol. 141 (2006) 1205-1218.
86. D.A. Dias, S. Urban, U. Roessner, A historical overview of natural products in drug discovery, Metabolites 2 (2012) 303-336.
87. N.D. Yuliana, A. Khatib, Y.H. Choi, R. Verpoorte, Metabolomics for bioactivity assessment of natural products, Phytother. Res. 25 (2011) 157-169.
88. T.A. Gulder, B.S. Moore, Chasing the treasures of the sea-bacterial marine natural products, Curr. Opin. Microbiol. 12 (2009) 252-260.
89. E. Esquenazi, Y.-L. Yang, J. Watrous, W.H. Gerwick, P.C. Dorrestein, Imaging mass spectrometry of natural products, Nat. Prod. Rep. 26 (2009) 1521-1534.
90. D. Staerk, J.R. Kesting, M. Sairafianpour, M. Witt, J. Asili, S.A. Emami, J.W. Jaroszewski, Accelerated dereplication of crude extracts using HPLC-PDA-MS-SPE-NMR: quinolinone alkaloids of Haplophyllum acutifolium, Phytochemistry 70 (2009) 1055-1061.
91. D.S. Wishart, Quantitative metabolomics using NMR, TrAC Trends Anal. Chem. 27 (2008) 228-237.
92. J.F. Imhoff, A. Labes, J. Wiese, Bio-mining the microbial treasures of the ocean: new natural products, Biotechnol. Adv. 29 (2011) 468-482.
93. L. Torras-Claveria, S. Berkov, O. Jáuregui, J. Caujapé, F. Viladomat, C. Codina, J. Bastida, Metabolic profiling of bioactive Pancratium canariense extracts by GC-MS, Phytochem. Anal. 21 (2010) 80-88.
94. Y. Hou, D.R. Braun, C.R. Michel, J.L. Klassen, N. Adnani, T.P. Wyche, T.S. Bugni, Microbial strain prioritization using metabolomics tools for the discovery of natural products, Anal. Chem. 84 (2012) 4277-4283.
95. T. Birkenstock, M. Liebeke, V. Winstel, B. Krismer, C. Gekeler, M.J. Niemiec, H. Bisswanger, M. Lalk, A. Peschel, Exometabolome analysis identifies pyruvate dehydrogenase as a target for the antibiotic triphenylbismuthdichloride in multiresistant bacterial pathogens, J. Biol. Chem. 287 (2012) 2887-2895.
96. M.F. Traxler, R. Kolter, A massively spectacular view of the chemical lives of microbes, Proc. Natl. Acad. Sci. U. S. A. 109 (2012) 10128-10129.
97. Y. Xu, R.D. Kersten, S.-J. Nam, L. Lu, A.M. Al-Suwailem, H. Zheng, W. Fenical, P. C. Dorrestein, B.S. Moore, P.-Y. Qian, Bacterial biosynthesis and maturation of the didemnin anti-cancer agents, J. Am. Chem. Soc. 134 (2012) 8625-8632.
98. K.L. Rinehart Jr., J.B. Gloer, R. Hughes Jr., H.E. Renis, J.P. McGovren, E.B. Swynenberg, D.A. Stringfellow, S.L. Kuentzel, L.H. Li, Didemnins: antiviral and antitumor depsipeptides from a Caribbean tunicate, Science 212 (1981) 933-935.
99. M. Tsukimoto, M. Nagaoka, Y. Shishido, J. Fujimoto, F. Nishisaka, S. Matsumoto, E. Harunari, C. Imada, T. Matsuzaki, Bacterial production of the tunicate-derived antitumor cyclic depsipeptide didemnin B, J. Nat. Prod. 74 (2011) 2329-2331.
100. S.K. Williamson, M.K. Wolf, M.A. Eisenberger, M. O'Rourke, W. Brannon, E.D. Crawford, Phase II evaluation of didemnin B in hormonally refractory metastatic prostate cancer, Investig. New Drugs 13 (1995) 167-170.
101. X. Ding, M.D. Vera, B. Liang, Y. Zhao, M.S. Leonard, M.M. Joullié, Structure-activity relationships of side-chain modified didemnins, Bioorg. Med. Chem. Lett. 11 (2001) 231-234.
102. V. Ribrag, D. Caballero, C. Fermé, E. Zucca, R. Arranz, J. Briones, C. Gisselbrecht, G. Salles, A.M. Gianni, H. Gomez, Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma, Haematologica 98 (2013) 357-363.
103. E. Zubia, M.J. Ortega, J. Salva, Natural products chemistry inmarine ascidians of the genus Aplidium, Mini-Rev. Org. Chem. 2 (2005) 389-399.
104. P. Qian, Y.S. Xu, P. Lai, Didemnin biosynthetic gene cluster in tistrella mobilis, WO 2013041969 A22013.